TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2943645
log Bayes Factor = 16.605
Chromosome 2   position 227,099,180  (GRCh37) Explore rs2943645 on Ensembl!
Variant rs2943645 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E11.9 Without complications
0.000 0.000 1.000
I25 Chronic ischaemic heart disease
0.000 0.000 1.000
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.001 0.999
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.004 0.996
I25.1 Atherosclerotic heart disease
0.000 0.014 0.986
I25.5 Ischaemic cardiomyopathy
0.000 0.052 0.948
E78.0 Pure hypercholesterolaemia
0.000 0.103 0.897
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.105 0.895
E78.5 Hyperlipidaemia, unspecified
0.000 0.139 0.861
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.161 0.838
E78.2 Mixed hyperlipidaemia
0.000 0.173 0.827
I25.2 Old myocardial infarction
0.000 0.173 0.827
I20-I25 Ischaemic heart diseases
0.000 0.197 0.803
I20.9 Angina pectoris, unspecified
0.000 0.201 0.799
I20 Angina pectoris
0.000 0.203 0.797
E78.4 Other hyperlipidaemia
0.000 0.211 0.789
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.211 0.789
E78.1 Pure hyperglyceridaemia
0.000 0.227 0.773
I25.3 Aneurysm of heart
0.000 0.244 0.756
E78.8 Other disorders of lipoprotein metabolism
0.000 0.247 0.753
E11 Non-insulin-dependent diabetes mellitus
0.000 0.256 0.744
E11.3 With ophthalmic complications
0.000 0.292 0.708
I25.6 Silent myocardial ischaemia
0.000 0.293 0.707
I20.0 Unstable angina
0.000 0.337 0.663
E10-E14 Diabetes mellitus
0.000 0.360 0.640
E10 Insulin-dependent diabetes mellitus
0.000 0.384 0.616
E10.1 With ketoacidosis
0.000 0.399 0.601
I22 Subsequent myocardial infarction
0.000 0.405 0.595
E78.3 Hyperchylomicronaemia
0.000 0.409 0.590
E11.8 With unspecified complications
0.000 0.436 0.564
E11.7 With multiple complications
0.000 0.467 0.533
E10.5 With peripheral circulatory complications
0.000 0.469 0.531
E13 Other specified diabetes mellitus
0.000 0.472 0.528
E78.6 Lipoprotein deficiency
0.000 0.482 0.518
E11.4 With neurological complications
0.000 0.493 0.507
E10.8 With unspecified complications
0.000 0.499 0.501
E10.0 With coma
0.000 0.513 0.487
E11.6 With other specified complications
0.000 0.519 0.481
E13.9 Without complications
0.000 0.533 0.466
E11.0 With coma
0.000 0.535 0.464
E12 Malnutrition-related diabetes mellitus
0.000 0.541 0.459
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.550 0.450
E10.7 With multiple complications
0.000 0.558 0.442
I22.8 Subsequent myocardial infarction of other sites
0.000 0.561 0.438
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.562 0.438
E10.9 Without complications
0.000 0.567 0.433
I23 Certain current complications following acute myocardial infarction
0.001 0.586 0.413
E10.6 With other specified complications
0.000 0.599 0.401
E11.1 With ketoacidosis
0.000 0.602 0.398
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.603 0.397
I25.4 Coronary artery aneurysm
0.001 0.621 0.378
E13.8 With unspecified complications
0.000 0.621 0.378
E13.7 With multiple complications
0.000 0.621 0.378
E13.6 With other specified complications
0.000 0.621 0.378
E13.5 With peripheral circulatory complications
0.000 0.621 0.378
E13.4 With neurological complications
0.000 0.621 0.378
E13.2 With renal complications
0.000 0.621 0.378
E13.1 With ketoacidosis
0.000 0.621 0.378
E13.0 With coma
0.000 0.621 0.378
E10.2 With renal complications
0.000 0.632 0.368
E10.3 With ophthalmic complications
0.000 0.638 0.362
I20.1 Angina pectoris with documented spasm
0.000 0.645 0.355
I20.8 Other forms of angina pectoris
0.000 0.645 0.355
E11.2 With renal complications
0.000 0.664 0.336
E13.3 With ophthalmic complications
0.000 0.668 0.331
E12.9 Without complications
0.000 0.671 0.329
E12.8 With unspecified complications
0.000 0.671 0.329
E12.7 With multiple complications
0.000 0.671 0.329
E12.6 With other specified complications
0.000 0.671 0.329
E12.5 With peripheral circulatory complications
0.000 0.671 0.329
E12.4 With neurological complications
0.000 0.671 0.329
E12.3 With ophthalmic complications
0.000 0.671 0.329
E12.2 With renal complications
0.000 0.671 0.329
E12.1 With ketoacidosis
0.000 0.671 0.329
E12.0 With coma
0.000 0.671 0.329
E10.4 With neurological complications
0.000 0.678 0.322
E11.5 With peripheral circulatory complications
0.000 0.686 0.314
I24 Other acute ischaemic heart diseases
0.000 0.687 0.312
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.001 0.703 0.296
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.001 0.703 0.296
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.001 0.703 0.296
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.001 0.703 0.296
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.001 0.703 0.296
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.001 0.703 0.296
I60 Subarachnoid haemorrhage
0.000 0.706 0.294
I60.9 Subarachnoid haemorrhage, unspecified
0.000 0.714 0.286
I60-I69 Cerebrovascular diseases
0.000 0.724 0.276
E14 Unspecified diabetes mellitus
0.000 0.725 0.275
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.000 0.730 0.269
Chapter IX Diseases of the circulatory system
0.000 0.735 0.265
I67 Other cerebrovascular diseases
0.000 0.739 0.261
I67.1 Cerebral aneurysm, nonruptured
0.000 0.739 0.261
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.001 0.741 0.259
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.000 0.742 0.258
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.000 0.744 0.256
I62 Other nontraumatic intracranial haemorrhage
0.000 0.756 0.244
I24.1 Dressler's syndrome
0.000 0.761 0.239
I61 Intracerebral haemorrhage
0.000 0.769 0.231
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.000 0.771 0.229
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.000 0.772 0.228
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.000 0.772 0.228
I67.2 Cerebral atherosclerosis
0.000 0.773 0.227
I21 Acute myocardial infarction
0.000 0.776 0.224
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.000 0.778 0.222
I05-I09 Chronic rheumatic heart diseases
0.000 0.780 0.220
I60.8 Other subarachnoid haemorrhage
0.000 0.784 0.216
I60.5 Subarachnoid haemorrhage from vertebral artery
0.000 0.789 0.211
I05 Rheumatic mitral valve diseases
0.000 0.789 0.211
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.000 0.790 0.210
I68 Cerebrovascular disorders in diseases classified elsewhere
0.000 0.792 0.208
I24.8 Other forms of acute ischaemic heart disease
0.000 0.793 0.207
E14.9 Without complications
0.000 0.795 0.205
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.795 0.205
I61.9 Intracerebral haemorrhage, unspecified
0.000 0.796 0.204
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.797 0.203
I23.8 Other current complications following acute myocardial infarction
0.001 0.797 0.202
E70-E90 Metabolic disorders
0.000 0.798 0.202
I10-I15 Hypertensive diseases
0.000 0.799 0.201
I05.2 Mitral stenosis with insufficiency
0.000 0.799 0.201
I67.0 Dissection of cerebral arteries, nonruptured
0.000 0.800 0.200
E14.4 With neurological complications
0.000 0.802 0.198
E14.7 With multiple complications
0.000 0.802 0.198
E14.5 With peripheral circulatory complications
0.000 0.802 0.198
E14.0 With coma
0.000 0.802 0.198
I61.3 Intracerebral haemorrhage in brain stem
0.000 0.803 0.197
E14.8 With unspecified complications
0.000 0.805 0.195
E14.2 Withrenal complications
0.000 0.805 0.195
I10 Essential (primary) hypertension
0.000 0.806 0.194
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.000 0.806 0.194
I21.4 Acute subendocardial myocardial infarction
0.000 0.810 0.190
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.811 0.189
I67.7 Cerebral arteritis, not elsewhere classified
0.000 0.812 0.188
I67.6 Nonpyogenic thrombosis of intracranial venous system
0.000 0.812 0.188
I67.5 Moyamoya disease
0.000 0.812 0.188
I67.4 Hypertensive encephalopathy
0.000 0.812 0.188
I67.3 Progressive vascular leukoencephalopathy
0.000 0.812 0.188
I60.4 Subarachnoid haemorrhage from basilar artery
0.000 0.817 0.182
E16 Other disorders of pancreatic internal secretion
0.000 0.820 0.180
I00-I02 Acute rheumatic fever
0.000 0.822 0.178
E16.2 Hypoglycaemia, unspecified
0.000 0.826 0.174
I62.1 Nontraumatic extradural haemorrhage
0.000 0.827 0.173
I05.9 Mitral valve disease, unspecified
0.000 0.832 0.168
T36-T50 Poisoning by drugs, medicaments and biological substances
0.168 0.832 0.000
E14.3 With ophthalmic complications
0.000 0.833 0.167
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.164 0.836 0.000
E73 Lactose intolerance
0.000 0.836 0.164
E14.6 With other specified complications
0.000 0.838 0.162
I21.X Presumed acute myicardial infaction (unconfirmed)
0.000 0.839 0.161
I05.1 Rheumatic mitral insufficiency
0.000 0.839 0.161
I68.0 Cerebral amyloid angiopathy
0.000 0.840 0.160
E85 Amyloidosis
0.000 0.840 0.160
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.840 0.160
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.158 0.842 0.000
T42.4 Benzodiazepines
0.157 0.843 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.157 0.843 0.000
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.844 0.156
T46 Poisoning by agents primarily affecting the cardiovascular system
0.155 0.845 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.154 0.846 0.000
I61.4 Intracerebral haemorrhage in cerebellum
0.000 0.846 0.153
I05.0 Mitral stenosis
0.000 0.847 0.153
I05.8 Other mitral valve diseases
0.000 0.848 0.152
I68.8 Other cerebrovascular disorders in diseases classified elsewhere
0.000 0.850 0.149
I68.2 Cerebral arteritis in other diseases classified elsewhere
0.000 0.850 0.149
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere
0.000 0.850 0.149
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.000 0.851 0.149
I09 Other rheumatic heart diseases
0.000 0.852 0.148
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.148 0.852 0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified
0.000 0.853 0.147
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.855 0.145
E77 Disorders of glycoprotein metabolism
0.000 0.855 0.145
E76 Disorders of glycosaminoglycan metabolism
0.000 0.855 0.145
E72 Other disorders of amino-acid metabolism
0.000 0.855 0.145
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.855 0.145
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.855 0.145
I13 Hypertensive heart and renal disease
0.000 0.855 0.144
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.144 0.855 0.000
E79 Disorders of purine and pyrimidine metabolism
0.000 0.856 0.144
I66.3 Occlusion and stenosis of cerebellar arteries
0.000 0.857 0.143
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.143 0.857 0.000
I07 Rheumatic tricuspid valve diseases
0.000 0.858 0.142
I61.6 Intracerebral haemorrhage, multiple localised
0.000 0.859 0.141
E14.1 With ketoacidosis
0.000 0.859 0.140
I66.0 Occlusion and stenosis of middle cerebral artery
0.000 0.860 0.140
I66.8 Occlusion and stenosis of other cerebral artery
0.000 0.861 0.139
I66.2 Occlusion and stenosis of posterior cerebral artery
0.000 0.861 0.139
I66.1 Occlusion and stenosis of anterior cerebral artery
0.000 0.861 0.139
I61.5 Intracerebral haemorrhage, intraventricular
0.000 0.861 0.139
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.139 0.861 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.862 0.138
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.000 0.863 0.137
E73.9 Lactose intolerance, unspecified
0.000 0.863 0.137
I66.9 Occlusion and stenosis of unspecified cerebral artery
0.000 0.864 0.136
E15 Nondiabetic hypoglycaemic coma
0.000 0.864 0.136
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.135 0.865 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.135 0.865 0.000
E85.4 Organ-limited amyloidosis
0.000 0.865 0.135
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries
0.000 0.865 0.134
E70 Disorders of aromatic amino-acid metabolism
0.000 0.866 0.134
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.134 0.866 0.000
T42.0 Hydantoin derivatives
0.133 0.867 0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.000 0.868 0.132
I08 Multiple valve diseases
0.000 0.870 0.130
T40.6 Other and unspecified narcotics
0.129 0.870 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.871 0.129
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.871 0.129
E16.4 Abnormal secretion of gastrin
0.000 0.871 0.129
E16.3 Increased secretion of glucagon
0.000 0.871 0.129
I02 Rheumatic chorea
0.000 0.872 0.128
I01 Rheumatic fever with heart involvement
0.000 0.872 0.128
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.127 0.872 0.000
I61.8 Other intracerebral haemorrhage
0.000 0.873 0.127
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.873 0.127
I69 Sequelae of cerebrovascular disease
0.000 0.874 0.126
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.126 0.874 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.126 0.874 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.126 0.874 0.000
T46.1 Calcium-channel blockers
0.125 0.875 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.125 0.875 0.000
E84 Cystic fibrosis
0.000 0.875 0.125
T38.1 Thyroid hormones and substitutes
0.124 0.875 0.000
T40.2 Other opioids
0.124 0.876 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.123 0.877 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.123 0.877 0.000
I21.3 Acute transmural myocardial infarction of unspecified site
0.000 0.878 0.122
T36 Poisoning by systemic antibiotics
0.121 0.879 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.121 0.879 0.000
E74 Other disorders of carbohydrate metabolism
0.000 0.880 0.120
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.120 0.880 0.000
E85.9 Amyloidosis, unspecified
0.000 0.881 0.119
T42.3 Barbiturates
0.119 0.881 0.000
I08.8 Other multiple valve diseases
0.000 0.881 0.119
T42.5 Mixed antiepileptics, not elsewhere classified
0.118 0.882 0.000
T42.2 Succinimides and oxazolidinediones
0.118 0.882 0.000
E73.8 Other lactose intolerance
0.000 0.882 0.118
E73.1 Secondary lactase deficiency
0.000 0.882 0.118
E73.0 Congenital lactase deficiency
0.000 0.882 0.118
E16.1 Other hypoglycaemia
0.000 0.883 0.117
I06 Rheumatic aortic valve diseases
0.000 0.884 0.116
I00 Rheumatic fever without mention of heart involvement
0.000 0.884 0.116
T43.4 Butyrophenone and thioxanthene neuroleptics
0.116 0.884 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.885 0.115
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.885 0.115
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.885 0.115
T46.5 Other antihypertensive drugs, not elsewhere classified
0.114 0.886 0.000
T38.9 Other and unspecified hormone antagonists
0.113 0.887 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.113 0.887 0.000
T38.7 Androgens and anabolic congeners
0.113 0.887 0.000
T38.5 Other oestrogens and progestogens
0.113 0.887 0.000
T38.4 Oral contraceptives
0.113 0.887 0.000
T38.2 Antithyroid drugs
0.113 0.887 0.000
T38.0 Glucocorticoids and synthetic analogues
0.113 0.887 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.113 0.887 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.000 0.887 0.113
T50.7 Analeptics and opioid receptor antagonists
0.113 0.887 0.000
T50.5 Appetite depressants
0.113 0.887 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.113 0.887 0.000
T50.1 Loop [high-ceiling] diuretics
0.113 0.887 0.000
T50.0 Mineralocorticoids and their antagonists
0.113 0.887 0.000
E85.3 Secondary systemic amyloidosis
0.000 0.888 0.112
T46.4 Angiotensin-converting-enzyme inhibitors
0.112 0.888 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.112 0.888 0.000
T40.1 Heroin
0.112 0.888 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.111 0.889 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.111 0.889 0.000
T46.7 Peripheral vasodilators
0.111 0.889 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.111 0.889 0.000
T47.0 Histamine H(2)-receptor antagonists
0.111 0.889 0.000
T40.5 Cocaine
0.111 0.889 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.111 0.889 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.111 0.889 0.000
E88 Other metabolic disorders
0.000 0.890 0.110
T50.4 Drugs affecting uric acid metabolism
0.109 0.891 0.000
T43.6 Psychostimulants with abuse potential
0.109 0.891 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.108 0.892 0.000
I15 Secondary hypertension
0.000 0.893 0.107
I09.8 Other specified rheumatic heart diseases
0.000 0.893 0.106
I09.2 Chronic rheumatic pericarditis
0.000 0.893 0.106
I09.1 Rheumatic diseases of endocardium, valve unspecified
0.000 0.893 0.106
I09.0 Rheumatic myocarditis
0.000 0.893 0.106
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.106 0.894 0.000
T40.8 Lysergide [LSD]
0.106 0.894 0.000
T40.7 Cannabis (derivatives)
0.106 0.894 0.000
T40.3 Methadone
0.106 0.894 0.000
T40.0 Opium
0.106 0.894 0.000
T47.4 Other laxatives
0.106 0.894 0.000
E80.2 Other porphyria
0.000 0.895 0.105
E75.6 Lipid storage disorder, unspecified
0.000 0.896 0.104
E75.5 Other lipid storage disorders
0.000 0.896 0.104
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.896 0.104
E75.3 Sphingolipidosis, unspecified
0.000 0.896 0.104
E75.2 Other sphingolipidosis
0.000 0.896 0.104
E75.1 Other gangliosidosis
0.000 0.896 0.104
E75.0 GM2 gangliosidosis
0.000 0.896 0.104
E71.3 Disorders of fatty-acid metabolism
0.000 0.896 0.104
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.896 0.104
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.896 0.104
E71.0 Maple-syrup-urine disease
0.000 0.896 0.104
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.896 0.104
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.896 0.104
E72.5 Disorders of glycine metabolism
0.000 0.896 0.104
E72.4 Disorders of ornithine metabolism
0.000 0.896 0.104
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.896 0.104
E72.2 Disorders of urea cycle metabolism
0.000 0.896 0.104
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.896 0.104
E72.0 Disorders of amino-acid transport
0.000 0.896 0.104
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.896 0.104
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.896 0.104
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.896 0.104
E76.2 Other mucopolysaccharidoses
0.000 0.896 0.104
E76.1 Mucopolysaccharidosis, type II
0.000 0.896 0.104
E76.0 Mucopolysaccharidosis, type I
0.000 0.896 0.104
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.896 0.104
E77.8 Other disorders of glycoprotein metabolism
0.000 0.896 0.104
E77.1 Defects in glycoprotein degradation
0.000 0.896 0.104
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.896 0.104
T50.8 Diagnostic agents
0.104 0.896 0.000
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.896 0.104
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.896 0.104
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.896 0.104
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.896 0.104
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.104 0.896 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.104 0.896 0.000
T47.7 Emetics
0.104 0.896 0.000
T47.6 Antidiarrhoeal drugs
0.104 0.896 0.000
T47.5 Digestants
0.104 0.896 0.000
T47.3 Saline and osmotic laxatives
0.104 0.896 0.000
T47.2 Stimulant laxatives
0.104 0.896 0.000
E85.8 Other amyloidosis
0.000 0.896 0.104
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.897 0.103
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.897 0.103
E79.1 Lesch-Nyhan syndrome
0.000 0.897 0.103
T43.9 Psychotropic drug, unspecified
0.103 0.897 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.103 0.897 0.000
I07.9 Tricuspid valve disease, unspecified
0.000 0.898 0.102
I07.8 Other tricuspid valve diseases
0.000 0.898 0.102
I07.2 Tricuspid stenosis with insufficiency
0.000 0.898 0.102
I07.0 Tricuspid stenosis
0.000 0.898 0.102
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.898 0.102
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries
0.000 0.898 0.102
I08.0 Disorders of both mitral and aortic valves
0.000 0.898 0.102
T50.6 Antidotes and chelating agents, not elsewhere classified
0.100 0.899 0.000
E40-E46 Malnutrition
0.000 0.901 0.099
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.099 0.901 0.000
I65.0 Occlusion and stenosis of vertebral artery
0.000 0.901 0.099
I11 Hypertensive heart disease
0.000 0.902 0.098
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.097 0.903 0.000
E80.6 Other disorders of bilirubin metabolism
0.000 0.903 0.097
I09.9 Rheumatic heart disease, unspecified
0.000 0.903 0.097
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.903 0.096
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.903 0.096
E70.2 Disorders of tyrosine metabolism
0.000 0.903 0.096
E70.1 Other hyperphenylalaninaemias
0.000 0.903 0.096
E70.0 Classical phenylketonuria
0.000 0.903 0.096
T42.1 Iminostilbenes
0.096 0.903 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.096 0.904 0.000
I08.9 Multiple valve disease, unspecified
0.000 0.904 0.096
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.096 0.904 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.095 0.905 0.000
T36.4 Tetracyclines
0.095 0.905 0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery
0.000 0.905 0.094
I12 Hypertensive renal disease
0.000 0.906 0.094
I01.9 Acute rheumatic heart disease, unspecified
0.000 0.908 0.092
I01.8 Other acute rheumatic heart disease
0.000 0.908 0.092
I01.2 Acute rheumatic myocarditis
0.000 0.908 0.092
I01.1 Acute rheumatic endocarditis
0.000 0.908 0.092
I01.0 Acute rheumatic pericarditis
0.000 0.908 0.092
I02.9 Rheumatic chorea without heart involvement
0.000 0.908 0.092
I02.0 Rheumatic chorea with heart involvement
0.000 0.908 0.092
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.909 0.091
E80.5 Crigler-Najjar syndrome
0.000 0.909 0.091
E80.3 Defects of catalase and peroxydase
0.000 0.909 0.091
E80.0 Hereditary erythropoietic porphyria
0.000 0.909 0.091
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.091 0.909 0.000
T37.5 Antiviral drugs
0.091 0.909 0.000
T37.4 Anthelminthics
0.091 0.909 0.000
T37.3 Other antiprotozoal drugs
0.091 0.909 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.091 0.909 0.000
T37.1 Antimycobacterial drugs
0.091 0.909 0.000
T37.0 Sulphonamides
0.091 0.909 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.091 0.909 0.000
T49.9 Topical agent, unspecified
0.090 0.909 0.000
T49.8 Other topical agents
0.090 0.909 0.000
T49.7 Dental drugs, topically applied
0.090 0.909 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.090 0.909 0.000
T49.5 Ophthalmological drugs and preparations
0.090 0.909 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.090 0.909 0.000
T49.3 Emollients, demulcents and protectants
0.090 0.909 0.000
T49.2 Local astringents and local detergents
0.090 0.909 0.000
T49.1 Antipruritics
0.090 0.909 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.090 0.910 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.090 0.910 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.090 0.910 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.090 0.910 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.090 0.910 0.000
T44.0 Anticholinesterase agents
0.090 0.910 0.000
T43.2 Other and unspecified antidepressants
0.090 0.910 0.000
E84.8 Cystic fibrosis with other manifestations
0.000 0.910 0.090
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.910 0.090
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.910 0.090
I65.1 Occlusion and stenosis of basilar artery
0.000 0.910 0.090
I65.8 Occlusion and stenosis of other precerebral artery
0.000 0.910 0.089
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.000 0.911 0.089
T36.9 Systemic antibiotic, unspecified
0.087 0.913 0.000
T36.8 Other systemic antibiotics
0.087 0.913 0.000
T36.7 Antifungal antibiotics, systemically used
0.087 0.913 0.000
T36.6 Rifamycins
0.087 0.913 0.000
T36.5 Aminoglycosides
0.087 0.913 0.000
T36.3 Macrolides
0.087 0.913 0.000
T36.2 Chloramphenicol group
0.087 0.913 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.087 0.913 0.000
T41.5 Therapeutic gases
0.087 0.913 0.000
T41.4 Anaesthetic, unspecified
0.087 0.913 0.000
T41.3 Local anaesthetics
0.087 0.913 0.000
T41.2 Other and unspecified general anaesthetics
0.087 0.913 0.000
T41.1 Intravenous anaesthetics
0.087 0.913 0.000
T41.0 Inhaled anaesthetics
0.087 0.913 0.000
I07.1 Tricuspid insufficiency
0.000 0.913 0.087
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.914 0.086
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.914 0.086
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.914 0.086
E74.2 Disorders of galactose metabolism
0.000 0.914 0.086
E74.1 Disorders of fructose metabolism
0.000 0.914 0.086
E74.0 Glycogen storage disease
0.000 0.914 0.086
E70.3 Albinism
0.000 0.914 0.086
E80.1 Porphyria cutanea tarda
0.000 0.915 0.085
I06.9 Rheumatic aortic valve disease, unspecified
0.000 0.916 0.083
I06.8 Other rheumatic aortic valve diseases
0.000 0.916 0.083
I06.2 Rheumatic aortic stenosis with insufficiency
0.000 0.916 0.083
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.917 0.083
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation
0.000 0.917 0.083
I70-I79 Diseases of arteries, arterioles and capillaries
0.000 0.919 0.081
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.000 0.919 0.081
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.080 0.920 0.000
T48.5 Anti-common-cold drugs
0.080 0.920 0.000
T48.4 Expectorants
0.080 0.920 0.000
T48.3 Antitussives
0.080 0.920 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.080 0.920 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.080 0.920 0.000
T48.0 Oxytocic drugs
0.080 0.920 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.920 0.080
I67.8 Other specified cerebrovascular diseases
0.000 0.920 0.080
E50-E64 Other nutritional deficiencies
0.000 0.921 0.079
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.079 0.921 0.000
E88.9 Metabolic disorder, unspecified
0.000 0.921 0.079
T36.0 Penicillins
0.078 0.922 0.000
I63 Cerebral infarction
0.000 0.923 0.077
I15.8 Other secondary hypertension
0.000 0.923 0.077
I15.2 Hypertension secondary to endocrine disorders
0.000 0.923 0.077
I69.0 Sequelae of subarachnoid haemorrhage
0.000 0.924 0.076
E88.3 Tumour lysis syndrome
0.000 0.925 0.075
I08.2 Disorders of both aortic and tricuspid valves
0.000 0.926 0.074
I78 Diseases of capillaries
0.000 0.926 0.073
I69.3 Sequelae of cerebral infarction
0.000 0.927 0.073
T45.0 Antiallergic and antiemetic drugs
0.072 0.928 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.071 0.928 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.929 0.071
E45 Retarded development following protein-energy malnutrition
0.000 0.929 0.071
E43 Unspecified severe protein-energy malnutrition
0.000 0.929 0.071
E42 Marasmic kwashiorkor
0.000 0.929 0.071
E41 Nutritional marasmus
0.000 0.929 0.071
E40 Kwashiorkor
0.000 0.929 0.071
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.929 0.071
E88.2 Lipomatosis, not elsewhere classified
0.000 0.929 0.070
T45.9 Primarily systemic and haematological agent, unspecified
0.070 0.930 0.000
T45.8 Other primarily systemic and haematological agents
0.070 0.930 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.070 0.930 0.000
T45.6 Fibrinolysis-affecting drugs
0.070 0.930 0.000
T45.4 Iron and its compounds
0.070 0.930 0.000
T45.3 Enzymes, not elsewhere classified
0.070 0.930 0.000
I06.1 Rheumatic aortic insufficiency
0.001 0.930 0.069
I15.1 Hypertension secondary to other renal disorders
0.000 0.930 0.070
E84.9 Cystic fibrosis, unspecified
0.000 0.930 0.069
T40.4 Other synthetic narcotics
0.069 0.931 0.000
I21.9 Acute myocardial infarction, unspecified
0.000 0.931 0.069
T45.1 Antineoplastic and immunosuppressive drugs
0.068 0.932 0.000
E88.8 Other specified metabolic disorders
0.000 0.932 0.068
I15.9 Seconday hypertension, unspecified
0.000 0.933 0.067
I15.0 Renovascular hypertension
0.000 0.933 0.066
T45.2 Vitamins, not elsewhere classified
0.066 0.934 0.000
E65-E68 Obesity and other hyperalimentation
0.000 0.934 0.066
I06.0 Rheumatic aortic stenosis
0.001 0.936 0.064
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.936 0.064
T43.3 Phenothiazine antipsychotics and neuroleptics
0.062 0.938 0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
0.000 0.939 0.061
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.939 0.061
E89.0 Postprocedural hypothyroidism
0.000 0.939 0.061
I70 Atherosclerosis
0.000 0.939 0.061
I63.8 Other cerebral infarction
0.000 0.939 0.061
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.940 0.060
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.941 0.059
I28 Other diseases of pulmonary vessels
0.000 0.941 0.059
I78.1 Naevus, nonneoplastic
0.000 0.941 0.059
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.000 0.941 0.059
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.943 0.057
E89.1 Postprocedural hypoinsulinaemia
0.000 0.943 0.057
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.943 0.057
E63 Other nutritional deficiencies
0.000 0.943 0.057
E50 Vitamin A deficiency
0.000 0.943 0.057
E60 Dietary zinc deficiency
0.000 0.943 0.057
E59 Dietary selenium deficiency
0.000 0.943 0.057

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.